METASTATIC LUNG NEUROENDOCRINE NEOPLASM
Clinical trials for METASTATIC LUNG NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new METASTATIC LUNG NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for METASTATIC LUNG NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for slowing advanced neuroendocrine tumors in major trial
Disease control OngoingThis study is testing if a drug called cabozantinib can slow the growth of advanced neuroendocrine tumors better than a placebo (inactive pill). It is for about 298 patients whose cancer has continued to grow despite receiving at least one prior standard treatment. The main goal …
Matched conditions: METASTATIC LUNG NEUROENDOCRINE NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Early trial aims to boost brain cancer fight
Disease control OngoingThis early-stage study is testing the safety and best dose of an experimental drug called berzosertib when given alongside standard whole-brain radiation therapy. It involves patients with lung cancer that has spread to the brain. The hope is that combining the drug with radiatio…
Matched conditions: METASTATIC LUNG NEUROENDOCRINE NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC